New Company Specializing in Stem Cell Platform for MS and Other Ills Raises $48.5M – Multiple Sclerosis News Today
Multiple Sclerosis News Today |
New Company Specializing in Stem Cell Platform for MS and Other Ills Raises $48.5M
Multiple Sclerosis News Today Magenta Therapeutics has completed its first round of financing, raising $48.5 million to develop ways of bringing stem cell transplants to more patients with autoimmune diseases, such as multiple sclerosis (MS), among other illnesses. The new company … |
